Associate Professor Rachel Conyers

Associate Professor Rachel Conyers MBBS FRACP PhD is a consultant paediatric oncologist and clinician scientist. A/Prof Conyers has a growing record in the field of pharmacogenomics, chemotherapy toxicity and Adolescent and Young Adult (AYA) Cancer. Her clinical focus is bone marrow transplantation and lymphoma and works across both the paediatric and adult sector (The Royal Children’s Hospital (RCH), Victorian Comprehensive Cancer Centre (VCCC), Melbourne. A/Prof Conyers has worked as a consultant oncologist with the Children’s Cancer Centre (RCH) and haematology service (VCCC) since 2013 and was acting head of bone marrow transplant and acting director of the Children’s Cancer Centre in 2017.

In 2016 A/Prof Conyers was awarded a Clinician Scientist Fellowship within Murdoch Children’s Research Institute (MCRI) to further her combined clinical and laboratory work in susceptibility to anthracycline toxicity within the Cardiac Regeneration laboratory together with Doctor David Elliott. A/Prof Conyers’ research focus is on the late effects of therapy, particularly anthracycline cardiomyopathy. The scope of her research includes creating functional models for cardiotoxicity, genomic analysis and acquisition of appropriate patient cohorts and she is the co-founder of the Australian Cardio-Oncology Registry which opened nationally from February 2019.